Bukwang Pharm (003000) - Total Liabilities

Latest as of September 2025: ₩132.16 Billion KRW ≈ $89.56 Million USD

Based on the latest financial reports, Bukwang Pharm (003000) has total liabilities worth ₩132.16 Billion KRW (≈ $89.56 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 003000 cash generation efficiency to assess how effectively this company generates cash.

Bukwang Pharm - Total Liabilities Trend (2007–2024)

This chart illustrates how Bukwang Pharm's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Bukwang Pharm to evaluate the company's liquid asset resilience ratio.

Bukwang Pharm Competitors by Total Liabilities

The table below lists competitors of Bukwang Pharm ranked by their total liabilities.

Company	Country	Total Liabilities
Teck Resources Limited F:TPT	Germany	€18.75 Billion
Goodwill E Health Info Co Ltd SHG:688246	China	CN¥892.07 Million
Caleres Inc NYSE:CAL	USA	$1.45 Billion
Shandong Hongyu Agricultural Machinery Co Ltd SHE:002890	China	CN¥139.93 Million
Norma Group AG NA O.N. XETRA:NOEJ	Germany	€713.83 Million
IGG Inc F:I91	Germany	€1.18 Billion
AS Tallink Grupp HE:TALLINK	Finland	€715.63 Million
Lontrue Co Ltd SHE:300175	China	CN¥73.85 Million

Liability Composition Analysis (2007–2024)

This chart breaks down Bukwang Pharm's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 003000 company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.60	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.39	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.28	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bukwang Pharm's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bukwang Pharm (2007–2024)

The table below shows the annual total liabilities of Bukwang Pharm from 2007 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩129.03 Billion ≈ $87.44 Million	-33.74%
2023-12-31	₩194.75 Billion ≈ $131.98 Million	+50.88%
2022-12-31	₩129.08 Billion ≈ $87.48 Million	+9.99%
2021-12-31	₩117.36 Billion ≈ $79.53 Million	-9.57%
2020-12-31	₩129.78 Billion ≈ $87.95 Million	+109.15%
2019-12-31	₩62.05 Billion ≈ $42.05 Million	-22.61%
2018-12-31	₩80.17 Billion ≈ $54.33 Million	+221.64%
2017-12-31	₩24.93 Billion ≈ $16.89 Million	+8.38%
2016-12-31	₩23.00 Billion ≈ $15.59 Million	-19.32%
2015-12-31	₩28.51 Billion ≈ $19.32 Million	+6.30%
2014-12-31	₩26.82 Billion ≈ $18.17 Million	-1.18%
2013-12-31	₩27.14 Billion ≈ $18.39 Million	-52.00%
2008-12-31	₩56.54 Billion ≈ $38.32 Million	+27.39%
2007-12-31	₩44.39 Billion ≈ $30.08 Million	--

About Bukwang Pharm

KO:003000 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$422.58 Million

₩623.56 Billion KRW

Market Cap Rank

#13412 Global

#449 in Korea

Share Price

₩6320.00

Change (1 day)

-3.95%

52-Week Range

₩3225.00 - ₩9600.00

All Time High

₩36947.85